|
|
| SG1408 / Sumgen Biotech (0 Trials) |
|
| SG1906 / Sumgen Biotech (0 Trials) |
|
| SG221 / Sana Biotech (0 Trials) |
|
| SG2285 / AstraZeneca (0 Trials) |
|
| SG233 / Sana Biotech (0 Trials) |
|
| SG239 / Sana Biotech (0 Trials) |
|
| SG242 / Sana Biotech (0 Trials) |
|
| SG2501 / Sumgen Biotech (0 Trials) |
|
| SG299 / Sana Biotech (0 Trials) |
|
| SG301 IV / Sumgen Biotech (0 Trials) |
|
| SG3299 / AstraZeneca (0 Trials) |
|
| SG404 / Sumgen Biotech (0 Trials) |
|
| SG418 / Sana Biotech (0 Trials) |
|
| SGE-516 / Sage Therapeutics (0 Trials) |
|
| SGF-3 / Merrimack (0 Trials) |
|
| SGI-1252 / Otsuka (0 Trials) |
|
| SGM-1019 / Evotec (0 Trials) |
|
| SGN-15 / Pfizer (0 Trials) |
|
| SGN-ALPV / Pfizer (0 Trials) |
|
| SGN-CD123A / Pfizer (0 Trials) |
|
| SGN-CD19B / Pfizer (0 Trials) |
|
| SGN-CD228A / Pfizer (0 Trials) |
|
| SGN-CD30C / Pfizer (0 Trials) |
|
| SGN-CD352A / Pfizer (0 Trials) |
|
| SGN-CD47M / Pfizer (0 Trials) |
|
| SGN-CD48A / Pfizer (0 Trials) |
|
| SGN-CD70A / Pfizer (0 Trials) |
|
| SGN-STNV / Pfizer (0 Trials) |
|
| SGR-1505 / Schrodinger (0 Trials) |
|
| SGR-2921 / Schrodinger (0 Trials) |
|
| SGR-3515 / Schrodinger (0 Trials) |
|
| SGT-001 / Solid BioSci (1 Trials) |
|
| SGT-53 / SynerGene Therap (3 Trials) |
|
| SGX126 / Eli Lilly (0 Trials) |
|
| SGX393 / Novartis, Eli Lilly (0 Trials) |
|
| SGX523 / Eli Lilly (0 Trials) |
|
| SH-110 / Shorla Oncology (0 Trials) |
|
| SH-111 / Shorla Pharma (0 Trials) |
|
| SH-580 / Sosei (0 Trials) |
|
| SH-879 / Nxera Pharma (0 Trials) |
|
| SH1573 / Nanjing Sanhome Pharma (0 Trials) |
|
| SH3051 / Nanjing Sanhome Pharma (0 Trials) |
|
| SH3765 / Nanjing Sanhome Pharma (0 Trials) |
|
| SH3809 / Nanjing Sanhome Pharma (0 Trials) |
|
| Shan5 (DTPwHB-Hib (Liquid) Pentavalent Combination Vaccine) / Sanofi (2 Trials) |
|
| Shanchol (oral cholera vaccine) / Sanofi (2 Trials) |
|
| Shanpoietin (recombinant human erythropoietin biosimilar) / Sanofi (0 Trials) |
|
| Shanvac B (recombinant DNA hepatitis B vaccine) / Sanofi (0 Trials) |
|
| shared neoantigen-targeting cell therapy for head and neck cancer / A2 Biotherap (0 Trials) |
|
| SHC026 / Nanjing Sanhome Pharma (0 Trials) |
|
| Shelcal K (calcium, vitamin D3 and vitamin K2) / Elder Pharma (0 Trials) |
|
| SHEN26 / Shenzhen Kexing Pharma, Shenzhen Antaiwei Biopharm (0 Trials) |
|
| shenqi fuzheng injection (SQ-001) / Livzon Pharma (0 Trials) |
|
| shIDO-ST / Tara I-O (0 Trials) |
|
| Shigamabs (cαStx1) / Sun Pharma (0 Trials) |
|
| Shigella flexneri 2a InvaplexAR / U.S. Army Medical Research and Development Command (0 Trials) |
|
| shigella sonnei vaccine (GSK3536852) / GSK (0 Trials) |
|
| Shiloah1000 / Ensol Biosci (0 Trials) |
|
| Shinbaro (GCSB-5) / GC Biopharma, LG Chem (0 Trials) |
|
| Shingrix (zoster vaccine recombinant adjuvanted) / GSK, Japan Vaccine (0 Trials) |
|
| SHJ002 / Sunhawk Vision Biotech (0 Trials) |
|
| Sholo inhibitor program / Mironid (0 Trials) |
|
| SHP-117 / Synchronicity Pharma, Alkermes (0 Trials) |
|
| SHP-636 / Takeda (0 Trials) |
|
| SHP099 / Novartis (0 Trials) |
|
| SHP623 / Takeda (0 Trials) |
|
| SHP628 / Takeda (0 Trials) |
|
| SHP648 / Takeda (0 Trials) |
|
| SHP656 / Synchronicity Pharma (0 Trials) |
|
| SHP681 / Takeda (0 Trials) |
|
| SHP844 / Novartis (0 Trials) |
|
| SHR 4640 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1222 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1501 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1603 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1702 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1703 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1707 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1708 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1802 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1806 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1816 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1819 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1901 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1906 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1916 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-1918 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-2002 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-2004 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-2010 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-2554 / Treeline Biosci (0 Trials) |
|
| SHR-8068 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A1201 (trastuzumab emtansine biosimilar) / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A1307 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A1403 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A1904 / EMD Serono (0 Trials) |
|
| SHR-A1909 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A1912 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A1921 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A2009 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR-A2102 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR0410 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR0532 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR1032 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR1601 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR170008 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR2150 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR2285 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR7280 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR7390 / Jiangsu Hengrui Pharma (2 Trials) |
|
| SHR8554 / Jiangsu Hengrui Pharma (0 Trials) |
|
| SHR9549 / Jiangsu Hengrui Pharma (0 Trials) |
|
| shRNA-modified CD34+ cell therapy / Kanglin Biotech (0 Trials) |
|
| SHS-006 / Nanjing Sanhome Pharma (0 Trials) |
|
| SHS-009 / Nanjing Sanhome Pharma (0 Trials) |
|
| SHS-010 / Nanjing Sanhome Pharma (0 Trials) |
|
| SHX-003 / Guangzhou Dazhou Biomedicine (0 Trials) |
|
| SHX-004/005/006/007/011 / Guangzhou Dazhou Biomedicine (0 Trials) |
|
| SHX-009 / Guangzhou Dazhou Biomedicine (0 Trials) |
|
| SHX-010 / Guangzhou Dazhou Biomedicine (0 Trials) |
|
| SI-000413 / Dong-A, Sinil Pharm (1 Trials) |
|
| SI-001 / StingInn (0 Trials) |
|
| si-544 / selectION (0 Trials) |
|
| danvilostomig (SI-B003) / Biokin Pharma (0 Trials) |
|
| SI-F019 / Biokin Pharma (0 Trials) |
|
| sialic acid extended release (SA-ER) / Ultragenyx, Nobelpharma (1 Trials) |
|
| sialidase inhibitors / Merck (MSD) (0 Trials) |
|
| sibeprenlimab (VIS649) / Otsuka (0 Trials) |
|
| sibofimloc (EB8018) / Enterome, Takeda (0 Trials) |
|
| Sibolone (tibolone) / Serum Institute of India (0 Trials) |
|
| SIBP-01 (trastuzumab biosimilar) / Sinopharm (0 Trials) |
|
| SIBP-02 (rituximab biosimilar) / Sinopharm (0 Trials) |
|
| SIBP-03 / Sinopharm (0 Trials) |
|
| SIBP-04 (bevacizumab biosimilar) / Sinopharm (0 Trials) |
|
| sickle cell anemia small molecule therapeutic / PharmaEssentia (0 Trials) |
|
| sickle cell anemia small molecule therapeutic / Orphagen (0 Trials) |
|
| SID 3712502 / University of Pittsburgh (0 Trials) |
|
| sifalimumab (MDX-1103) / AstraZeneca (0 Trials) |
|
| sifuvirtide (FS-0101) / FusoGen Pharma (0 Trials) |
|
| SIG-001 / Eli Lilly (0 Trials) |
|
| SIG-002 / Eli Lilly (0 Trials) |
|
| SIG-003 / Eli Lilly (0 Trials) |
|
| SIG-005 / Eli Lilly (0 Trials) |
|
| SIG-009 / Eli Lilly (0 Trials) |
|
| SIG-015 / Eli Lilly (0 Trials) |
|
| SIG-018 / Eli Lilly (0 Trials) |
|
| SIG-020 / Eli Lilly (0 Trials) |
|
| SIG-1451 / Signum Biosci (0 Trials) |
|
| SIG002 / Arugula Sci (0 Trials) |
|
| SIG007 / Eli Lilly (0 Trials) |
|
| SIG1322 / Signum Dermalogix (0 Trials) |
|
| signal-transduction inhibitors / TransCell Therap (0 Trials) |
|
| Signature Cord Prime (SIG001) / Arugula Sci (0 Trials) |
|
| Signifor (pasireotide) / Recordati (0 Trials) |
|
| Signifor LAR (pasireotide long acting release) / Recordati (2 Trials) |
|
| sigvotatug vedotin (SGN-B6A) / Pfizer (0 Trials) |
|
| siHSP47-NP / PDX Pharma (0 Trials) |
|
| Sii HibPro (hemophilus Type B conjugate vaccine) / Serum Institute of India (0 Trials) |
|
| SII OncoBCG (BCG vaccine) / Serum Institute of India (0 Trials) |
|
| SII Q-vac (diphtheria, tetanus, pertusis & hepatitis B vaccine) / Serum Institute of India (0 Trials) |
|
| SII Rabivax (rabies vaccine) / Serum Institute of India (0 Trials) |
|
| Sii Somastin (somatostatin) / Serum Institute of India (0 Trials) |
|
| SII T- Vac (diphtheria + tetanus vaccine) / Serum Institute of India (0 Trials) |
|
| SII-YFV / Serum Institute of India (0 Trials) |
|
| SIIPL Tdap IPV / Serum Institute of India (0 Trials) |
|
| SIKD1977 / Samik Pharma (0 Trials) |
|
| silatecan (AR-67) / Vivacitas (1 Trials) |
|
| sildenafil / Generic mfg. (95 Trials) |
|
| sildenafil (KW25084) / Alvogen Korea (0 Trials) |
|
| sildenafil cream (SST-6006) / Daré Biosci, Strategic Science & Technologies (0 Trials) |
|
| sildenafil oral film / Generic mfg. (0 Trials) |
|
| Siliq (brodalumab) / Bausch Health (14 Trials) |
|
| silmitasertib (CX-4945) / Senhwa Biosci, University of California (2 Trials) |
|
| silodosin / Generic mfg. (11 Trials) |
|
| Silverzine Tulle (Silver Sulfadiazine) / MinaPharm (6 Trials) |
|
| SIM0235 / Simcere (0 Trials) |
|
| SIM0237 / Simcere (0 Trials) |
|
| SIM0272 / Simcere (0 Trials) |
|
| SIM0348 / Simcere (0 Trials) |
|
| SIM0361 / Simcere (0 Trials) |
|
| SIM0368 / Simcere (0 Trials) |
|
| SIM0409 / Simcere, Vivoryon (0 Trials) |
|
| SIM1803-1A / Simcere, WuXi AppTec (0 Trials) |
|
| SIM930 / Simcere (0 Trials) |
|
| Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis (0 Trials) |
|
| simcere kechuanning / Simcere (0 Trials) |
|
| Simcor (simvastatin/niacin extended-release formulation) / AbbVie (1 Trials) |
|
| Simdax (levosimendan IV) / AbbVie (78 Trials) |
|
| simlukafusp alfa (RG7461) / Roche (4 Trials) |
|
| simmerafil (TPN171H) / Shanghai Inst. of Materia Medica, Vigonvita Life Sci, Topharman (0 Trials) |
|
| simmiparib (SMOCL-9112) / Shanghai Acebright Pharma (0 Trials) |
|
| simmitecan / HaiHe Biopharma (0 Trials) |
|
| simmitinib (SYHA1817) / CSPC Pharma (0 Trials) |
|
| simmitinib (SYHA1817) / CSPC Pharma (0 Trials) |
|
| simoctocog alpha/von Willebrand Factor (OCTA101) / Octapharma (0 Trials) |
|
| simoladagene autotemcel (OTL-101) / Kyowa Kirin (1 Trials) |
|
| Simponi (golimumab) / Merck (MSD), Mitsubishi Tanabe, J&J (37 Trials) |
|
| simridarlimab (IBI-322) / Innovent Biologics (0 Trials) |
|
| simtuzumab (GS 6624) / Gilead (2 Trials) |
|
|